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The unfolded protein response (UPR) is triggered when the 
protein folding machinery in the ER becomes overwhelmed 
by an accumulation of misfolded or unfolded proteins. This   
occurs under a broad range of physiological conditions, such 
as viral infections, chemical disruption of ER calcium stores 
or disulfide bonds, and inhibition of protein glycosylation   
(Marciniak and Ron, 2006). The UPR signals a transcriptional re-
sponse resulting in synthesis of resident ER protein folding and 
degradative enzymes (Travers et al., 2000), leading to ER expan-
sion (Bernales et al., 2006; Schuck et al., 2009). The ER trans-
membrane protein, Ire1, is a key signaling element in the UPR   
consisting of an intra-ER lumenal domain that directly or indi-
rectly senses misfolded proteins and a cytoplasmic tail with pro-
tein kinase and endoribonuclease domains (Sidrauski and Walter, 
1997). Sensing of misfolded proteins causes lateral oligomeriza-
tion of the Ire1 lumenal domains, trans-autophosphorylation, 
and activation of the nuclease (Shamu and Walter, 1996). 
In the yeast Saccharomyces cerevisiae, ER stress causes the 
ribonuclease domain of Ire1 to excise a 252-nt translational- 
inhibitory intron from HAC1 mRNA (Cox and Walter, 1996). 
The  separated  HAC1  exons  are  joined  by  nonconventional 
splicing in the cytoplasm by tRNA ligase. Finally, the mature, 
spliced mRNA is translated into Hac1 protein, a bZIP transcrip-
tion factor for ER chaperones and protein folding enzymes that 
restores ER function. Although remarkable progress has been 
made in understanding UPR signaling, how the enhanced ER 
function is attenuated when protein folding is restored has re-
mained a mystery. Two studies in this issue (Rubio et al. and 
Chawla et al.) both point toward a key role for the Ire1 kinase 
domain in the down-regulation of the UPR, though in surpris-
ingly different ways.
The unfolded protein response is an ancient cellular path-
way  for  rapidly  responding  to  endoplasmic  reticulum 
stress. Two studies in this issue (Rubio et al. 2011. J. Cell. 
Biol.  doi:10.1083/jcb.201007077  and  Chawla  et  al. 
2011. J. Cell. Biol. doi:10.1083/jcb.201008071) pro-
vide  insight  into  how  the  unfolded  protein  response  is 
tamped down to restore normal endoplasmic reticulum 
function. Although both papers implicate the Ire1 kinase 
domain as the key effector of the off-switch mechanism, 
alternate models for how this is achieved are proposed.
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Previous studies showed that mutations in the catalytic 
site of the Ire1 kinase prevented HAC1 mRNA splicing and 
UPR target gene expression (Cox et al., 1993; Mori et al., 1993). 
However, the kinase activity itself is not absolutely required 
for  Ire1’s  RNase  function. When  the ATP-competitive  drug,   
1NM-PP1, binds to an Ire1 with a mutated nucleotide-binding   
pocket, the ribonuclease activity in response to ER stress is 
switched on in the absence of phosphorylation (Papa et al., 
2003). Similarly, the antiviral endoribonuclease and pseudo-
kinase, RNase L (Zhou et al., 1993), is highly homologous in its 
C-terminal half to the cytoplasmic portion of Ire1 (Dong et al., 
2001). RNase L, which lacks protein kinase activity, has a ribo-
nuclease domain that is activated by 2-5-oligo(rA) produced 
during viral infections (Dong and Silverman, 1999). Thus, 
RNase  L  activation/inactivation  are  uncoupled  from  kinase   
activity. So what, then, is the function of the Ire1 kinase?
In Rubio et al. (2011), a double mutant within the Ire1   
kinase domain (D797N,K799N) was designed to block phospho-
ryl transfer while preserving ATP binding (Rubio et al., 2011). 
This Ire1 kinase-inactive mutant was nevertheless functional for 
ribonuclease activity. Interestingly, although the Ire1 kinase ac-
tivity was dispensable for RNase function, it appeared critical 
for turning off Ire1 function. Mutant Ire1 oligomerized in the 
ER membrane, cleaved HAC1 pre-mRNA, and promoted syn-
thesis of Hac1 protein, induction of UPR target genes, and ER 
expansion in vivo. The mutant Ire1 was activated by misfolded 
proteins; however, unlike wild-type IRE1, the mutant Ire1 failed to 
deactivate late in the stress response, and its presence reduced 
cell  survival  of  ER  stressed  yeast. The  severe  growth  defect 
was linked to UPR overload of the ER import machinery with   
additional pleiotropic effects. Thus, Ire1 kinase activity appeared 
to be required for disassembly of the Ire1 signaling complex and 
enhanced  cell  survival  in  a  homeostatic  control  mechanism. 
These studies reinforced the view that the Ire1 kinase regulates 
RNase activity while revealing a critical role for phosphorylation 
in the homeostatic feedback of the UPR. The authors propose 
that trans-autophosphorylation on sites within the Ire1 kinase do-
main, in a C-lobe region termed the hyperphosphorylation loop 
(HPL), is required for rapid de-oligomerization of Ire1 as a reset 
mechanism (Fig. 1 a). Consequently, it was proposed that phos-
phoryl transfer by the Ire1 kinase is important for Ire1 shutoff.
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even after removal of Tm). This suggested that phosphoryla-
tion activity was not the principle driver for the shutoff of Ire1 
ribonuclease activity.
Characterization of additional single site and multisite   
Ire1  mutants  and  their  behavior  in  combination  provided 
valuable insight into how dephosphorylation of the activation 
segment might serve as a shutoff switch for the UPR (Chawla   
et al., 2011). The simplest model that can explain the aggregate 
behavior of mutants tested in the two studies, anchored by prece-
dents set in other protein kinase systems (for review see Nolen 
et al., 2004), centers on the phosphorylation-dependent transi-
tion of the activation segment between alternate conformation 
states: one compatible, the other incompatible with Ire1 ribo-
nuclease function. The ribonuclease-incompatible state is likely 
organized by interaction of the dephosphorylated activation seg-
ment, with a subset of active site residues in the kinase catalytic 
cleft. Phosphorylation of hydroxyl-bearing residues within the 
activation segment (namely Ser840, S841, and Thr 844) disrupts 
this off-state conformation, transitioning the activation segment 
into a conformation supportive of Ire1 ribonuclease function. 
With this model, the behavior of the characterized mutants can 
be rationalized by the sum of perturbatory effects on the ability 
of Ire1 to transfer phosphate versus effects on the stability of the 
off-state conformation of the activation segment.
In closing, the newfound understanding of how the auto-
kinase activity of Ire1 regulates the turn-on and shutoff of Ire1 
ribonuclease function helps make sense of two striking features 
A  contrasting  view  of  Ire1  de-activation  is  presented 
in  Chawla  et  al.  (2011),  obtained  through  characterization 
of an extensive panel of Ire1 kinase domain mutants. These 
authors found that mutation of some but not all catalytic resi-
dues and residues in the kinase activation segment, includ-
ing  sites  of  autophosphorylation,  resulted  in  a  prolonged 
presence  of  spliced  HAC1  mRNA  after  UPR  induction  in 
yeast by tunicamycin (Tm). Homeostasis of unspliced HAC1 
mRNA, BIP mRNA, and protein and carboxyl peptidase Y 
activity was restored at late times after treatment with Tm in 
yeast with wild-type Ire1, but not in Ire1 cells. Recovery 
occurred more rapidly upon Tm removal from culture me-
dium in the wild type than in mutant Ire1 cells. Chawla et al. 
(2011) reasoned that because the activation segment of Ire1 
is autophosphorylated during UPR (Shamu & Walter, 1996; 
Lee et al., 2008), dephosphorylation might deactivate Ire1 
(Fig. 1 b). This model is in contrast to Rubio et al. (2011), 
in which phosphorylation not dephosphorylation is the driver 
of Ire1 deactivation. To test their model, Chawla et al. (2011) 
generated a phosphomimetic version of Ire1 (S840D/S841D/
T844D within the activation segment), predicted to leave ki-
nase phosphotransfer function intact but render the enzyme 
unresponsive to the action of phosphatases (Chawla et al., 
2011). Strikingly, the triple mutation resulted in an Ire1 that 
could still respond to Tm and could autophosphorylate ro-
bustly, but which did not return to baseline after resolution 
of the ER stress (i.e., HAC1 mRNA continued to be spliced 
Figure 1.  Turning off the UPR. Schematics of phosphorylation (a)- and dephosphorylation (b)-driven models for attenuation of Ire1 activity. Domains colored 
light blue, green, yellow, and dark blue correspond to Ire1 lumenal, kinase N-lobe, kinase C-lobe, and endoribonuclease domains, respectively. Kinase 
domain loop elements in purple and light blue correspond to the activation segment and hyper phosphorylated loop (HPL), respectively. P corresponds to 
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that differentiate RNase L from Ire1. As noted, although RNase L   
shares many of the architectural features of a bona fide pro-
tein kinase domain, it has dispensed with phosphoryl transfer 
function  (Dong  and  Silverman,  1999).  Coincident  with  this   
loss, RNase L appears to lack a recognizable activation seg-
ment and substrate recognition infrastructure including the   
P + 1 loop, helix EF, and likely helix G. Lacking an activation 
segment that transitions between productive and nonproduc-
tive conformations in response to autophosphorylation signals 
removes the premium on maintaining protein kinase function 
or substrate recognition infrastructure. But this begs the ques-
tion, what was lost first, the activation segment or kinase activ-
ity? A remaining conundrum is why shutoff of compromised 
Ire1 mutants requires ER stress to become active in the first 
place? One might imagine constitutive activation in the ab-
sence of ER stress. The shutoff of compromised mutant be-
havior is reminiscent of 1-NM-PP1 activatable mutant Ire1 
proteins (Papa et al., 2003). In the absence of ER stress, this 
small molecule is not sufficient to activate Ire1 ribonuclease 
activity but is absolutely required for mutant Ire1 activation 
in the presence of ER stress. One would expect that if both 
cytoplasmic (autophosphorylation or ligand binding) and lu-
menal (detection of unfolded protein) signals are required for 
Ire1 activation, then loss of either one should be sufficient for 
shutoff. However, this is not the case and will surely be fodder 
for future studies.
Finally, it is worth noting that these two papers may be 
relevant to a long list of human diseases characterized by ER 
stress, including cancer, neurodegenerative diseases, diabetes 
mellitus, and atherosclerosis (Marciniak and Ron, 2006). There-
fore, the findings could eventually provide a basis for novel 
therapeutic strategies that regulate UPR shutdown. For instance, 
if the Chawla et al. (2011) model turns out to be correct, phos-
phatases that dephosphorylate Ire1 might be therapeutic targets 
for inhibitor drugs to sustain the UPR.
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